Pharmaceuticals

IVD Microsphere Market Size, Share & Trends Analysis Report, By Type (Magnetic Microspheres, Latex Microspheres, Fluorescent and Colored Microspheres, & Standard Microspheres and Others), By Application (Immunoturbidimetry, Immunochromatography, Chemiluminescence, Protein Purification, & Molecular Diagnosis and Others), By Region, Forecasts, 2025-2034

Global IVD Microsphere Market Size Was valued at USD 342.1 Mn in 2024 and is predicted to reach USD 618.7 Mn by 2034 at a 6.3% CAGR during the forecast period for 2025-2034. In vitro diagnostic technology relies heavily on IVD (In-vitro-diagnosis) microspheres, which are small, spherical particles that typically range in size from nanometers to micrometers. Numerous materials, including silica, polystyrene, and polymethylmethacrylate, can be use...

Report ID: 3050  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 170

Kidney Preservation Market Size, Share & Trends Analysis Report, By Solution (University of Wisconsin Solution, Histidin-Tryptophan-Ketoglutarate (HTK) Solution, Celsior Solution, Hypertonic Citrate Adenine (HC-A), Institut Georges Lopez-1 (IGL-1) Solution, Others), By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Donor Type, By End-user, By Region, Forecasts, 2025-2034

Global Kidney Preservation Market Size Was valued at USD 64.2 Mn in 2024 and is predicted to reach USD 138.5 Mn by 2034 at a 8.2% CAGR during the forecast period for 2025-2034. Kidney preservation is the process of keeping a kidney viable after it has been removed from a donor but before it is transplanted into a recipient. This technique is necessary because if blood flow is disrupted, the kidney is susceptible to damage from a lack of oxygen a...

Report ID: 3116  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 160

TNF Biosimilars Market Size, Share & Trends Analysis Report By Drug (Adalimumab Biosimilar, Infliximab Biosimilar, Certolizumab Biosimilar, Etanercept Biosimilar, and Golimumab Biosimilar), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), Region And Segment Forecasts, 2025-2034

TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034.  Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, which leads to inflammation. TNF inhibitors are the drug that stops inflammation. They are mainly indicated for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, anklyosing Spo...

Report ID: 1072  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Peptide Oligonucleotide Conjugate Market Size, Share & Trends Analysis Report, By Product Type (Therapeutic Conjugates, Diagnostic Conjugates), By Technology (Liquid Phase Synthesis, Solid Phase Synthesis), By Method (Direct, Indirect), By Targeting Agent (Antibodies, Aptamers (RNA Aptamers, DNA Aptamers)), By Molecule Type (Macromolecules, Small Molecules), By Application, By Chain Length, By Linker Chemistry, By End-user, By Region, Forecasts, 2025-2034

Peptide Oligonucleotide Conjugate Market Size is predicted to grow with a 12.5% CAGR during the forecast period for 2025-2034. A new class of biotherapeutics known as peptide oligonucleotide conjugates combines the selectivity of oligonucleotides with the cell-penetrating and targeting capabilities of peptides. This hybrid approach overcomes long-standing challenges in delivering genetic material across cellular membranes while retaining a hig...

Report ID: 3120  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

NAMPT Inhibitor Market Size, Share & Trends Analysis By Molecule Type (Small Molecules, Biologics), By Line of Treatment (1st Line, 2nd Line), By Indication (Acute Respiratory Distress Syndrome, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma), By Route of Administration (Oral, Intravenous), By Therapeutic Area (Respiratory Disorders, Oncological), by Region, And by Segment Forecasts, 2025-2034

Global NAMPT Inhibitor Market Size is predicted to grow with a 10.9% CAGR during the forecast period for 2025-2034. A NAMPT (nicotinamide phosphoribosyltransferase) inhibitor is a pharmaceutical agent that interferes with the function of the NAMPT enzyme, essential for the synthesis of NAD+ (nicotinamide adenine dinucleotide) within cells. NAMPT inhibitors are under investigation as potential cancer treatments, especially for tumors exhibiting e...

Report ID: 3121  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 160

Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted Therapy (Onpattro, Inotersen, Vyndaqel/Vyndamax), Supportive Therapy, Pipeline Therapy), By Disease Type (Hereditary Transthyretin Amyloidosis (Polyneuropathy, Cardiomyopathy, Mixed Type), Wild Type Amyloidosis), By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Global Transthyretin Amyloidosis Treatment Market Size is valued at USD 5.5 Bn in 2024 and is predicted to reach USD 11.7 Bn by the year 2034 at a 8.0% CAGR during the forecast period for 2025-2034. Transthyretin amyloidosis (ATTR) is an uncommon and progressive condition resulting from the misfolding of transthyretin (TTR) proteins, which leads to amyloid accumulation in organs and tissues, mostly impacting the heart and nervous system. Pati...

Report ID: 2890  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 165

Temporary Healthcare Staffing Market Size, Share & Trends Analysis Report By Type (Physician Staffing, Per Diem Nurse Staffing, Travel Nurse Staffing, Allied Healthcare Staffing (Pharmacists and Pharmacy Technicians Staffing, Therapists and Rehabilitation Professionals Staffing, Other Clinical Professionals Staffing)), By Application, By End User, By Region, And By Segment Forecasts, 2024-2031

Global Temporary Healthcare Staffing Market Size is valued at USD 61.4 Bn in 2023 and is predicted to reach USD 85.3 Bn by the year 2031 at a 4.35% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The expansion of the temporary healthcare staffing industry is propelled by the increasing scarcity of proficient medical practitioners, in addition to the cost-effectiveness linked to te...

Report ID: 2401  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (PNH, Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder), By End Use, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034.

Global Ultomiris Drug Market Size is valued at USD 3.9 Bn in 2024 and is predicted to reach USD 44.3 Bn by the year 2034 at a 27.7% CAGR during the forecast period for 2025-2034. Ultomiris (ravulizumab-cwvz) is commonly used to treat a combination of severe blood and nerve problems that are uncommon. Ultomiris drug is used to treat conditions where the immune system mistakenly attacks its own red blood cells or nerve cells that carry and receive...

Report ID: 3113  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 170

Robotic Neurosurgery Market Size, Share & Trends Analysis Report By Product Type (Services, Robotic Systems, Instruments And Accessories), By Application (Spinal Neurosurgery And Cranial Neurosurgery), By End-User (Hospitals And Ambulatory Surgical Center), By Region, And By Segment Forecasts, 2025-2034.

Global Robotic Neurosurgery Market size is valued at USD 405.6 Mn in 2024 and is predicted to reach USD 1,672.6 Mn by the year 2034 at a 15.7% CAGR during the forecast period for 2025-2034. The use of robotic technology to help neurosurgeons perform intricate operations on the brain, spine, and nervous system with more control, precision, and minimally invasive techniques is known as robotic neurosurgery. Real-time navigation, high-definition im...

Report ID: 3114  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 170

Bruton Tyrosine Kinase (BTK) Inhibitors Market Size, Share & Trends Analysis Report By Product Type (IC50<1nM, 1nM< IC50<5nM, IC50?5nM), By Application, By Distribution channel, By End-User, By Region, And By Segment Forecasts, 2023-2031.

Bruton Tyrosine Kinase (BTK) Inhibitors Market Size is predicted to grow with a 15.0% CAGR during the forecast period for 2025-2034. Non-receptor tyrosine kinase inhibitors that target B-cell receptors are called Bruton's tyrosine kinase (BTK) inhibitors to modulate B-cell signalling, proliferation, growth, and differentiation. B-cell leukaemia, lymphomas, haematological malignancies, and graft versus host disease are treated with Bruton's tyr...

Report ID: 1242  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180